Skip to main content

Gritstone bio, Inc.

GRTSDelisted Mar 5, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001656634

Gritstone bio, Inc. was delisted on Mar 5, 2025; its insiders filed their last Form 4 on Apr 8, 2025; 56 institutions reported holding it in 13F filings for Q3 2024, worth $20.7M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Gritstone bio, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of GRTS: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders102192−9
Shares34.9M40.7K42.4M+7.58M (+21.8%)
Value$318.2M$372.0K$458.4M+$140.5M (+44.2%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Gritstone bio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to GRTS in Q3 2021
InstitutionSharesValue% of portfolio
DG Capital Management, LLC83,162$898.0K0.18%
ACT Capital Management, LLC74,000$799.0K0.41%
Mirabella Financial Services LLP65,400$706.0K0.09%
Franklin Resources Inc40,700$440.0K0.00%
Jane Street Group, LLC40,345$436.0K0.00%
Gsa Capital Partners LLP40,303$435.0K0.04%
State Board of Administration of Florida Retirement System25,624$277.0K0.00%
SG Americas Securities, LLC24,297$262.0K0.00%
Belvedere Trading LLC19,391$175.0K0.05%
HighVista Strategies LLC14,453$156.0K0.10%
Hershey Trust Co8,791$95.0K0.00%
Blackstone Group Inc.8,761$95.0K0.00%

Sold out (21)

Institutions that held Gritstone bio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Not filed for Q3 2021 yet (1)

Institutions that held Gritstone bio, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding GRTS in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
QS Investors, LLC40,700$372.0K